Significance and assessment of margin status in ductal carcinoma in situ of the breast

Advances in Anatomic Pathology

Volumn 8, Issue 6, 2001, Pages 338-344

  Millar, Ewan K A ^a   Leong, Anthony S Y ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Breast neoplasms; Breast conserving therapy; Ductal carcinoma in situ; Local recurrence; Margins; Multifocality; Tumor size

Indexed keywords

BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHY; PAGET NIPPLE DISEASE; PATHOLOGY; RADIOGRAPHY; REVIEW; RISK FACTOR; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS;

EID: 0035514686     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/00125480-200111000-00004     Document Type: Review

References (46)

1. Fisher ER, Constantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17: Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995;75:1310-9.
2. Sneige N, McNeese MD, Atkinson EN, et al. Ductal carcinoma in-situ treated with lumpectomy and irradiation: histopathologic analysis of 49 specimens with emphasis on risk factors and long term results. Hum Pathol 1995;26:642-9.
3. Cutuli B, Teissier E, Piat J-M, et al. Radical surgery and conservative treatment of ductal carcinoma in-situ of the breast. Eur J Cancer 1992;28:649-54.
4. Cheng L, Al-Kaisi K, Gordon NH, et al. Relationship between the size and margin status of ductal carcinoma in-situ of the breast and residual disease. J Natl Cancer Inst 1997;89:1356.
5. Solin LJ, Recht A, Fourquet A, et al. Ten-year results of breast conserving surgery and definitive irradiation for intraductal carcinoma (duct carcinoma in-situ) of the breast. Cancer 1991;68:2337-44.
6. Silverstein MJ, Wiseman JR, Gamagami P, et al. Intraductal carcinoma of the breast (208 cases): clinical factors influencing treatment choice. Cancer 1990;66:102-8. (Pubitemid 20197092)
7. Fisher ER, Leeming R, Anderson S, et al. Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 1991;47:139-47.
8. Silverstein MJ, Barth A, Poller DN, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in-situ of the breast. Eur J Cancer 1995:31A:1425-7.
9. Vicini FA, Goldstein NS, Kestin LL. Pathologic and technical considerations in the treatment of ductal carcinoma in-situ of the breast with lumpectomy and radiation therapy. Ann Oncol, 1999;10:883-90. (Pubitemid 29424565)
10. Holland PA, Gandhi A, Knox WF, et al. The importance of complete excision in the prevention of local recurrence in ductal carcinoma of the breast. Br J Cancer 1998;77:110-4. (Pubitemid 28029781)
11. Lagios MD. Pathologic procedures for mammographically detected ductal carcinoma in-situ. In: Silverstein MJ, ed. Ductal carcinoma in-situ of the breast. Baltimore: Williams and Wilkins, 1997:189-193.
12. Graham RA, Homer MJ, Sigler CJ, et al. The efficacy of specimen radiography in evaluating surgical margins of in palpable breast carcinoma. AJR Am J Roentgenol 1994;162:33-6. (Pubitemid 24043669)
13. Lee CH, Carter D. Detecting residual tumor after excisional biopsy of impalpable breast carcinoma: efficacy of comparing preoperative mammograms with radiographs of the biopsy specimen. AJR Am J Roentgenol 1995;164:81-6.
14. Guidi AJ, Connolly JL, Harris JR, et al. The relationship between shaved margin and inked margins status in breast excision specimens. Cancer 1997;79:1568-73. (Pubitemid 27154789)
15. The Consensus Conference Committee. Consensus Conference on the Classification of Ductal Carcinoma In Situ. Cancer 1997;80:1798-802.
16. Saarela AO, Paloneva TK, Rissanen TJ, et al. Contaminants of positive histologic margins and residual tumor after lumpectomy for early stage breast cancer; a prospective study with special reference to touch preparation cytology. J Surg Oncol 1997;66:248-53. (Pubitemid 28013699)
17. Cox CE, Hyacinthe N, Gonzalez RJ et al. Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in-situ. Ann Surg Oncol 1997;4: 644-9. (Pubitemid 127725493)
18. England DW, Chan SY, Stonelake PS, et al. Assessment of excision margins following wide local excision for breast carcinoma using specimen scrape cytology and tumor bed biopsy. Eur J Surg Oncol 1994;20:425-9. (Pubitemid 24281957)
19. Klimberg VS, Westbrook KC, Korourian S. Ease of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998;5:220-6. (Pubitemid 28249311)
20. Klimberg VS, Harms S, Korourian S. Assessing margin status. Surg Oncol 1999;8:77-84 (Pubitemid 30224700)
21. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. Thee management of ductal carcinoma insitu (DCIS). Can Med Assoc J 1998;158(suppl 3):S27-34.
22. Holland R, Faverly DRG. Whole organ studies. In: Silverstein MJ, ed. Ductal carcinoma in-situ of the breast. Baltimore: Williams and Wilkins, 1997:233-40.
23. Bellamy COC, McDonald C, Salter DM, et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993;24:16-23. (Pubitemid 23046667)
24. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in-situ. Cancer 1999;85:616-28. (Pubitemid 29075283)
25. Silverstein MJ, Gierson ED, Colburn WJ. Can intraduct breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer 1994;73:2985-9. (Pubitemid 24170772)
26. Fechner RE. Ductal carcinoma involving the lobule of the breast: a source of confusion with lobular carcinoma in-situ. Cancer 1971;28:274-81.
27. Goldstein NS, Lacerna M, Vicini F. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in-situ of the breast. Am J Clin Pathol 1998;110:357-67. (Pubitemid 28406994)
28. Kestin LL, Goldstein NS, Lacerna MD, et al. Factors associated with local recurrence of mammographically detected ductal carcinoma in-situ in patients given breast conserving therapy. Cancer 2000;88:596-607. (Pubitemid 30056935)
29. Silverstein MJ, Lagios, Craig PH, et al. A prognostic index for ductal carcinoma in-situ of the breast. Cancer 1996;77:2267-74.
30. Faverly D, Burgers L, Bult, et al. Three dimensional imaging of mammary ductal carcinoma in-situ: clinical implications. Semin Diagn Pathol 1994;11:193-8 (Pubitemid 24308079)
31. Recht A, Van DJ, Fentiman IS, et al. Third meeting of the DCIS working party of the EORTC: conference report. Eur J Cancer 1994;28:626-9.
32. Silverstein MJ. Predicting residual disease and local recurrence in patients with ductal carcinoma in situ. J Natl Cancer Inst 1997;89:1330-1.
33. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Advent Breast Project (NSABP) eight year update of protocol B-17: intraduct carcinoma. Cancer 1999;86:429-38. (Pubitemid 29347405)
34. Marks LB, Prosnitz LR. Lumpectomy with and without radiation for early-stage breast cancer and DCIS. Oncology 1997,11:1361-8.
35. Kurtz JM, Jacquemier J, Amalric R, et al. Risk factors for breast recurrence in premenopausal and post menopausal patients with ductal cancers treated by conservation therapy. Cancer 1990;65:1867-78. (Pubitemid 20116664)
36. Solin LJ, Kurtz J, Fourquet A, et al. Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in-situ of the breast. J Clin Oncol 1996;14:754-63. (Pubitemid 26085518)
37. Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in-situ (DCIS). Int J Radiat Oncol Biol Phys 1997;38:949-57. (Pubitemid 27353673)
38. Page D, Dupont WD, Rodgers LW, et al. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-200.
39. Hiramatsu H, Bornstein BA, Recht A, et al. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in-situ. Cancer J Sci Am 1995;1:55-61.
40. McCormick B, Rosen PP, Kinne D, et al. Duct carcinoma in-situ of the breast: an analysis of local control after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:105-11.
41. Page DL, Lagios MD. Pathological analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 Trial. Cancer 1995;75:1219-22.
42. Silverstein MJ. Prognostic factors and local recurrence in patients with ductal carcinoma in-situ of the breast. Breast J 1998;4:349-62. (Pubitemid 28503709)
43. Ellis IO, Poller DN. Ductal carcinoma in-situ (DCIS) of the breast. In: Kirkham N, Lemoine NR, eds. Progress in pathology. vol 2. Edinburgh: Churchill Livingstone, 1995:47-87.
44. Fourquet A, Zafrani B, Campana F, et al. Institut Curie experience. In: Silverstein MJ, ed. Ductal carcinoma in-situ. Baltimore: Williams and Wilkins, 1997:391-7.
45. Arnesson LG, Smeds S, Fagerburg G, et al. Follow-up of two treatment modalities for ductal cancer in situ of the breast. Br J Surg 1989;76:672-5. (Pubitemid 19188768)
46. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in-situ of the breast. N Engl J Med 1999;340:1455-61. (Pubitemid 29220544)